Contribution of high-fat diet-induced PCSK9 upregulation to a mouse model of PCOS is mediated partly by SREBP2

in Reproduction
View More View Less
  • 1 Department of Physiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, China

Correspondence should be addressed to D Yuan or L Yue; Email: yuandongzhi@scu.edu.cn or yuelimin@scu.edu.cn

*(W-j Guo and Y-c Wang contributed equally to this work)

Restricted access

The incidence of polycystic ovary syndrome (PCOS) due to high-fat diet (HFD) consumption has been increasing significantly. However, the mechanism by which a HFD contributes to the pathogenesis of PCOS has not been elucidated. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key protein that regulates cholesterol metabolism. Our previous study revealed abnormally high PCSK9 levels in serum from patients with PCOS and in serum and hepatic and ovarian tissues from PCOS model mice, suggesting that PCSK9 is involved in the pathogenesis of PCOS. However, the factor that induces high PCSK9 expression in PCOS remains unclear. In this study, Pcsk9 knockout mice were used to further explore the role of PCSK9 in PCOS. We also studied the effects of a HFD on the expression of PCSK9 and sterol regulatory element-binding protein 2 (SREBP2), a regulator of cholesterol homeostasis and a key transcription factor that regulates the expression of PCSK9, and the roles of these proteins in PCOS pathology. Our results indicated HFD may play an important role by inducing abnormally high PCSK9 expression via SREBP2 upregulation. We further investigated the effects of an effective SREBP inhibitor, fatostain, and found that it could reduce HFD-induced PCSK9 expression, ameliorate hyperlipidemia and improve follicular development in PCOS model mice. Our study thus further elucidates the important role of an HFD in the pathogenesis of PCOS and provides a new clue in the prevention and treatment of this disorder.

 

     An official journal of

    Society for Reproduction and Fertility

 

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 758 758 611
Full Text Views 17 17 13
PDF Downloads 20 20 16
  • Abifadel M, Rabes JP, Devillers M, Munnich A, Erlich D, Junien C, Varret M & Boileau C 2009 Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease. Human Mutation 30 520529. (https://doi.org/10.1002/humu.20882)

    • Search Google Scholar
    • Export Citation
  • Azhar S, Leers-Sucheta S & Reaven E 2003 Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and ‘selective’ pathway connection. Frontiers in Bioscience 8 s998s1029. (https://doi.org/10.2741/1165)

    • Search Google Scholar
    • Export Citation
  • Banaszewska B, Pawelczyk L, Spaczynski RZ, Dziura J & Duleba AJ 2007 Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial. Journal of Clinical Endocrinology and Metabolism 92 456461. (https://doi.org/10.1210/jc.2006-1988)

    • Search Google Scholar
    • Export Citation
  • Bingham B, Shen R, Kotnis S, Lo CF, Ozenberger BA, Ghosh N, Kennedy JD, Jacobsen JS, Grenier JM & Distefano PS et al.2006 Proapoptotic effects of NARC 1 (= PCSK9), the gene encoding a novel serine proteinase. Cytometry: Part A 69 11231131. (https://doi.org/10.1002/cyto.a.20346)

    • Search Google Scholar
    • Export Citation
  • Brothers KJ, Wu S, Divall SA, Messmer MR, Kahn CR, Miller RS, Radovick S, Wondisford FE & Wolfe A 2010 Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor. Cell Metabolism 12 295305. (https://doi.org/10.1016/j.cmet.2010.06.010)

    • Search Google Scholar
    • Export Citation
  • Caldwell AS, Middleton LJ, Jimenez M, Desai R, Mcmahon AC, Allan CM, Handelsman DJ & Walters KA 2014 Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology 155 31463159. (https://doi.org/10.1210/en.2014-1196)

    • Search Google Scholar
    • Export Citation
  • Cardenas H, Herrick JR & Pope WF 2002 Increased ovulation rate in gilts treated with dihydrotestosterone. Reproduction 123 527533. (https://doi.org/10.1530/rep.0.1230527)

    • Search Google Scholar
    • Export Citation
  • Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Orio F, Di Fede G & Rini G 2007 Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. Journal of Clinical Endocrinology and Metabolism 92 25002505. (https://doi.org/10.1210/jc.2006-2725)

    • Search Google Scholar
    • Export Citation
  • Chang HY, Wu JR, Gao WY, Lin HR, Chen PY, Chen CI, Wu MJ & Yen JH 2019 The cholesterol-modulating effect of methanol extract of pigeon pea (Cajanus cajan (L.) Millsp.) leaves on regulating LDLR and PCSK9 expression in HepG2 cells. Molecules 24 493. (https://doi.org/10.3390/molecules24030493)

    • Search Google Scholar
    • Export Citation
  • Cherian-Shaw M, Puttabyatappa M, Greason E, Rodriguez A, Vandevoort CA & Chaffin CL 2009 Expression of scavenger receptor-BI and low-density lipoprotein receptor and differential use of lipoproteins to support early steroidogenesis in luteinizing macaque granulosa cells. Endocrinology 150 957965. (https://doi.org/10.1210/en.2008-0619)

    • Search Google Scholar
    • Export Citation
  • Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D & Pasquali R et al.2014 The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. European Journal of Endocrinology 171 P1P29. (https://doi.org/10.1530/EJE-14-0253)

    • Search Google Scholar
    • Export Citation
  • Cui X, Jing X, Wu X, Bi X, Liu J, Long Z, Zhang X, Zhang D, Jia H & Su D et al.2017 Abnormal expression levels of BMP15/Smad1 are associated with granulosa cell apoptosis in patients with polycystic ovary syndrome. Molecular Medicine Reports 16 82318236. (https://doi.org/10.3892/mmr.2017.7658)

    • Search Google Scholar
    • Export Citation
  • Cunningham D, Danley DE, Geoghegan KF, Griffor MC, Hawkins JL, Subashi TA, Varghese AH, Ammirati MJ, Culp JS & Hoth LR et al.2007 Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia. Nature Structural and Molecular Biology 14 413419. (https://doi.org/10.1038/nsmb1235)

    • Search Google Scholar
    • Export Citation
  • de Melo AS, Dias SV, Cavalli Rde C, Cardoso VC, Bettiol H, Barbieri MA, Ferriani RA & Vieira CS 2015 Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause. Reproduction 150 R11R24. (https://doi.org/10.1530/REP-14-0499)

    • Search Google Scholar
    • Export Citation
  • Dokras A, Sarwer DB, Allison KC, Milman L, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, Gnatuk CL & Estes SJ et al.2016 Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS. Journal of Clinical Endocrinology and Metabolism 101 29662974. (https://doi.org/10.1210/jc.2016-1896)

    • Search Google Scholar
    • Export Citation
  • Dong B, Singh AB, Azhar S, Seidah NG & Liu J 2015 High-fructose feeding promotes accelerated degradation of hepatic LDL receptor and hypercholesterolemia in hamsters via elevated circulating PCSK9 levels. Atherosclerosis 239 364374. (https://doi.org/10.1016/j.atherosclerosis.2015.01.013)

    • Search Google Scholar
    • Export Citation
  • Eberle D, Hegarty B, Bossard P, Ferre P & Foufelle F 2004 SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86 839848. (https://doi.org/10.1016/j.biochi.2004.09.018)

    • Search Google Scholar
    • Export Citation
  • Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN & PCOS/Troglitazone Study Group 2006 Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 91 4853. (https://doi.org/10.1210/jc.2005-1329)

    • Search Google Scholar
    • Export Citation
  • Folsom AR, Peacock JM, Boerwinkle E & Atherosclerosis Risk in Communities (ARIC) Study Investigators 2009 Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial disease. Atherosclerosis 202 211215. (https://doi.org/10.1016/j.atherosclerosis.2008.03.009)

    • Search Google Scholar
    • Export Citation
  • Franks S 2008 Polycystic ovary syndrome in adolescents. International Journal of Obesity 32 10351041. (https://doi.org/10.1038/ijo.2008.61)

    • Search Google Scholar
    • Export Citation
  • Gambineri A, Pelusi C, Vicennati V, Pagotto U & Pasquali R 2002 Obesity and the polycystic ovary syndrome. International Journal of Obesity and Related Metabolic Disorders 26 883896. (https://doi.org/10.1038/sj.ijo.0801994)

    • Search Google Scholar
    • Export Citation
  • Gao S, Shi Z, Li X, Li W, Wang Y, Liu Z & Jiang J 2018 Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma. Oncology Reports 39 19191929. (https://doi.org/10.3892/or.2018.6265)

    • Search Google Scholar
    • Export Citation
  • Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS & Goldstein JL 2003 Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. PNAS 100 1202712032. (https://doi.org/10.1073/pnas.1534923100)

    • Search Google Scholar
    • Export Citation
  • Hughesdon PE 1982 Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called ‘hyperthecosis’. Obstetrical and Gynecological Survey 37 5977. (https://doi.org/10.1097/00006254-198202000-00001)

    • Search Google Scholar
    • Export Citation
  • Jeong HJ, Lee HS, Kim KS, Kim YK, Yoon D & Park SW 2008 Sterol-dependent regulation of proprotein convertase subtilisin/kexin type 9 expression by sterol-regulatory element binding protein-2. Journal of Lipid Research 49 399409. (https://doi.org/10.1194/jlr.M700443-JLR200)

    • Search Google Scholar
    • Export Citation
  • Jia YJ, Xu RX, Sun J, Tang Y & Li JJ 2014 Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats. Journal of Translational Medicine 12 103. (https://doi.org/10.1186/1479-5876-12-103)

    • Search Google Scholar
    • Export Citation
  • Krysa JA, Ooi TC, Proctor SD & Vine DF 2017 Nutritional and lipid modulation of PCSK9: effects on cardiometabolic risk factors. Journal of Nutrition 147 473481. (https://doi.org/10.3945/jn.116.235069)

    • Search Google Scholar
    • Export Citation
  • Kumar P, Nawani N, Malhotra N, Malhotra J, Patil M, Jayakrishnan K, Kar S, Jirge PR & Mahajan N 2013 Assisted reproduction in polycystic ovarian disease: a multicentric trial in India. Journal of Human Reproductive Sciences 6 4953. (https://doi.org/10.4103/0974-1208.112382)

    • Search Google Scholar
    • Export Citation
  • Kysenius K, Muggalla P, Matlik K, Arumae U & Huttunen HJ 2012 PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling. Cellular and Molecular Life Sciences 69 19031916. (https://doi.org/10.1007/s00018-012-0977-6)

    • Search Google Scholar
    • Export Citation
  • Lai H, Jia X, Yu Q, Zhang C, Qiao J, Guan Y & Kang J 2014 High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome. Biology of Reproduction 91 127. (https://doi.org/10.1095/biolreprod.114.120063)

    • Search Google Scholar
    • Export Citation
  • Legro RS, Dodson WC, Kunselman AR, Stetter CM, Kris-Etherton PM, Williams NI, Gnatuk CL, Estes SJ, Allison KC & Sarwer DB et al.2016 Benefit of delayed fertility therapy with preconception weight loss over immediate therapy in obese women with PCOS. Journal of Clinical Endocrinology and Metabolism 101 26582666. (https://doi.org/10.1210/jc.2016-1659)

    • Search Google Scholar
    • Export Citation
  • Luo LL, Huang J, Fu YC, Xu JJ & Qian YS 2008 Effects of tea polyphenols on ovarian development in rats. Journal of Endocrinological Investigation 31 11101118. (https://doi.org/10.1007/BF03345661)

    • Search Google Scholar
    • Export Citation
  • Maciel GA, Baracat EC, Benda JA, Markham SM, Hensinger K, Chang RJ & Erickson GF 2004 Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 89 53215327. (https://doi.org/10.1210/jc.2004-0643)

    • Search Google Scholar
    • Export Citation
  • Marcondes FK, Bianchi FJ & Tanno AP 2002 Determination of the estrous cycle phases of rats: some helpful considerations. Brazilian Journal of Biology 62 609614. (https://doi.org/10.1590/s1519-69842002000400008)

    • Search Google Scholar
    • Export Citation
  • McCartney CR, Blank SK, Prendergast KA, Chhabra S, Eagleson CA, Helm KD, Yoo R, Chang RJ, Foster CM & Caprio S et al.2007 Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. Journal of Clinical Endocrinology and Metabolism 92 430436. (https://doi.org/10.1210/jc.2006-2002)

    • Search Google Scholar
    • Export Citation
  • Miettinen HE, Rayburn H & Krieger M 2001 Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice. Journal of Clinical Investigation 108 17171722. (https://doi.org/10.1172/JCI13288)

    • Search Google Scholar
    • Export Citation
  • Moran LJ, Pasquali R, Teede HJ, Hoeger KM & norman RJ 2009 Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertility and Sterility 92 19661982. (https://doi.org/10.1016/j.fertnstert.2008.09.018)

    • Search Google Scholar
    • Export Citation
  • R & Shah G 2018 High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats. Reproduction 155 141151. (https://doi.org/10.1530/REP-17-0584)

    • Search Google Scholar
    • Export Citation
  • Piao MX, Bai JW, Zhang PF & Zhang YZ 2015 PCSK9 regulates apoptosis in human neuroglioma u251 cells via mitochondrial signaling pathways. International Journal of Clinical and Experimental Pathology 8 27872794.

    • Search Google Scholar
    • Export Citation
  • Rocha MP, Marcondes JA, Barcellos CR, Hayashida SA, Curi DD, Da Fonseca ÂM, Bagnoli VR & Baracat EC 2011 Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecological Endocrinology 27 814819. (https://doi.org/10.3109/09513590.2010.508852)

    • Search Google Scholar
    • Export Citation
  • Roy S, Mahesh VB & Greenblatt RB 1962 Effect of dehydroepiandrosterone and delta4-androstenedione on the reproductive organs of female rats: production of cystic changes in the ovary. Nature 196 4243. (https://doi.org/10.1038/196042a0)

    • Search Google Scholar
    • Export Citation
  • Salehi M, Bravo-Vera R, Sheikh A, Gouller A & Poretsky L 2004 Pathogenesis of polycystic ovary syndrome: what is the role of obesity? Metabolism: Clinical and Experimental 53 358376. (https://doi.org/10.1016/j.metabol.2003.10.005)

    • Search Google Scholar
    • Export Citation
  • Sathyapalan T, Kilpatrick ES, Coady AM & Atkin SL 2009 The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 94 103108. (https://doi.org/10.1210/jc.2008-1750)

    • Search Google Scholar
    • Export Citation
  • Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, Basak A, Prat A & Chretien M 2003 The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. PNAS 100 928933. (https://doi.org/10.1073/pnas.0335507100)

    • Search Google Scholar
    • Export Citation
  • Song WJ, Shi X, Zhang J, Chen L, Fu SX & Ding YL 2018 Akt-mTOR signaling mediates abnormalities in the proliferation and apoptosis of ovarian granulosa cells in patients with polycystic ovary syndrome. Gynecologic and Obstetric Investigation 83 124132. (https://doi.org/10.1159/000464351)

    • Search Google Scholar
    • Export Citation
  • Steckler T, Manikkam M, Inskeep EK & Padmanabhan V 2007 Developmental programming: follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone. Endocrinology 148 35323540. (https://doi.org/10.1210/en.2007-0339)

    • Search Google Scholar
    • Export Citation
  • Sui GG, Xiao HB, Lu XY & Sun ZL 2018 Naringin activates AMPK resulting in altered expression of SREBPs, PCSK9, and LDLR to reduce body weight in obese C57BL/6J mice. Journal of Agricultural and Food Chemistry 66 89838990. (https://doi.org/10.1021/acs.jafc.8b02696)

    • Search Google Scholar
    • Export Citation
  • Tavori H, Rashid S & Fazio S 2015 On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects. Atherosclerosis 238 264270. (https://doi.org/10.1016/j.atherosclerosis.2014.12.017)

    • Search Google Scholar
    • Export Citation
  • van Houten EL & Visser JA 2014 Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function? Reproductive Biology 14 3243. (https://doi.org/10.1016/j.repbio.2013.09.007)

    • Search Google Scholar
    • Export Citation
  • Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M & Bondy CA 1999 Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biology of Reproduction 61 353357. (https://doi.org/10.1095/biolreprod61.2.353)

    • Search Google Scholar
    • Export Citation
  • Wang M, Zhao D, Xu L, Guo W, Nie L, Lei Y, Long Y, Liu M, Wang Y & Zhang X et al.2019 Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome. Metabolism: Clinical and Experimental 94 4758. (https://doi.org/10.1016/j.metabol.2019.02.002)

    • Search Google Scholar
    • Export Citation
  • Wu CY, Tang ZH, Jiang L, Li XF, Jiang ZS & Liu LS 2012 PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway. Molecular and Cellular Biochemistry 359 347358. (https://doi.org/10.1007/s11010-011-1028-6)

    • Search Google Scholar
    • Export Citation
  • Wu XQ, Wang YQ, Xu SM, Liu JF, Bi XY, Wang ZQ & Zhang JP 2017 The WNT/beta-catenin signaling pathway may be involved in granulosa cell apoptosis from patients with PCOS in North China. Journal of Gynecology Obstetrics and Human Reproduction 46 9399. (https://doi.org/10.1016/j.jgyn.2015.08.013)

    • Search Google Scholar
    • Export Citation
  • Yang SH, Xu RX, Cui CJ, Wang Y, Du Y, Chen ZG, Yao YH, Ma CY, Zhu CG & Guo YL et al.2018 Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism. Cardiovascular Diabetology 17 48. (https://doi.org/10.1186/s12933-018-0689-9)

    • Search Google Scholar
    • Export Citation
  • Yesilaltay A, Dokshin GA, Busso D, Wang L, Galiani D, Chavarria T, Vasile E, Quilaqueo L, Orellana JA & Walzer D et al.2014 Excess cholesterol induces mouse egg activation and may cause female infertility. PNAS 111 E4972E4980. (https://doi.org/10.1073/pnas.1418954111)

    • Search Google Scholar
    • Export Citation
  • Zaid A, Roubtsova A, Essalmani R, Marcinkiewicz J, Chamberland A, Hamelin J, Tremblay M, Jacques H, Jin W & Davignon J et al.2008 Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration. Hepatology 48 646654. (https://doi.org/10.1002/hep.22354)

    • Search Google Scholar
    • Export Citation